Announcements

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

The editorial office of Cancers would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Cancers received 20527 review reports from contributors across 89 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.

The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Cancers.

We are pleased to announce that four new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in January 2026. We wish our new members success in both their research and their efforts to develop the journal.

Further details about the Editorial Board of Cancers can be found on the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

• A full academic CV;
• A short cover letter that detailing your interest in the position.

We are pleased to announce that seven new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in January 2026. We wish our new member success in both their research and their efforts to develop the journal.

Name: Dr. Pietro Addeo
Affiliation: Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre-Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, 67098 Strasbourg, France
Interests: pancreatic cancer; pancreatic surgery; liver cancer; liver surgery; liver metastases; cholangiocarcinoma; hepatocarcinoma; neuroendocrine tumors; biliary cancer; biliary surgery

Name: Prof. Dr. Subhash C. Chauhan
Affiliation: Department of Immunology and Microbiology, University of Texas Rio Grande Valley, Edinburg, TX, USA
Interests: cancer; cancer diagnosis; cancer treatment; molecular cancer therapeutics; cancer prevention; early cancer diagnosis; nanotherapies; nanomedicine; tumor microenvironment; antibody therapies; immunotherapy

Name: Prof. Dr. Analisa DiFeo
Affiliation: Departments of Obstetrics and Gynecology and Pathology, University of Michigan, Ann Arbor, MI 48109, USA
Interests: cancer biomarkers; translational research; gynecological cancers; cancer therapies

Name: Dr. Shulan Tian
Affiliation: Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
Interests: cancer genomics; bioinformatics; precision medicine; data science; machine learning

Name: Dr. Henry K. Wong
Affiliations: ¹ Department of Dermatology, School of Medicine, University of California San Diego, San Diego, CA, USA; ² Dermatology Section, Department of Medicine, VA San Diego Health System, San Diego, CA, USA
Interests: T cell malignancies; lymphoma; epigenetic; biomarker; immune microenvironment; DNA methylation

Name: Dr. Paul Reynolds
Affiliation: School of Medicine, University of St Andrews, Medical and Biological Sciences Building, North Haugh, St Andrews KY16 9TF, UK
Interests: cancer genetics; molecular pathology; signal transduction; drug resistance; targeted therapy; translational research

Name: Dr. Zaed Z. R. Hamady
Affiliations: ¹ Human Development & Health, University of Southampton, Southampton SO16 6YD, UK; ² University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK
Interests: pancreatic cancer; new onset diabetes millitus; early detection; faster diagnosis; screening; prevention

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

• A full academic CV;
• A short cover letter detailing your interest in the position.

World Cancer Day draws global attention to the ongoing fight against cancer—one of the leading causes of morbidity and mortality worldwide. Observed annually on 4 February, World Cancer Day unites individuals, communities, researchers, clinicians, and policymakers in a shared commitment to reduce the global cancer burden and improve outcomes for patients everywhere.

Aligned with this year’s theme and the United Nations Sustainable Development Goal 3 (Good Health and Well-Being), the initiative calls for greater awareness, early detection, equitable access to care, and sustained investment in cancer research and innovation. From prevention and diagnosis to treatment and survivorship, addressing cancer requires coordinated, multidisciplinary efforts across healthcare systems and scientific communities worldwide.

In support of World Cancer Day, selected MDPI journals highlight cutting-edge research across the cancer continuum, including advances in oncology, diagnostics, therapeutics, public health, and patient-centred care. Through curated articles, Special Issues, and expert-led webinars, these journals aim to foster knowledge exchange and collaboration to accelerate progress toward a future where cancer prevention and treatment are accessible, effective, and equitable for all.

In 2026, MDPI is honored to support World Cancer Day through a monthly awareness ries beginning in February. Each session will focus on a key cancer awareness theme, showcasing cutting-edge research and expert insights through specially curated landing pages and a dedicated webinar series. Through this special activity, we aim to sustain engagement and cross-disciplinary collaboration throughout the year. Below is the list of events. You may click on the respective links (updated throughout the year, closer to each event month) to access the individual event pages.

Keynote Speakers
Dr. Xiang Xue, University of New Mexico, USA	Dr. Federico Pio Fabrizio, Kore University of Enna, Italy	Dr. Anis Ahmad, University of Miami, USA	Dr. Hiroaki Kiyokawa, Northwestern University, USA

Register for this webinar for free here!

“Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment”
by Sandhya Shukla, Arvind Kumar Shukla, Adarsha Mahendra Upadhyay, Navin Ray, Fowzul Islam Fahad, Arulkumar Nagappan, Sayan Deb Dutta and Raj Kumar Mongre
Onco 2025, 5(2), 27; https://doi.org/10.3390/onco5020027

“Comprehensive Analysis of Advancement in Optical Biosensing Techniques for Early Detection of Cancerous Cells”
by Ayushman Ramola, Amit Kumar Shakya and Arik Bergman
Biosensors 2025, 15(5), 292; https://doi.org/10.3390/bios15050292

“Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies”
by Valencia Mc Neil and Seung Won Lee
Cancers 2025, 17(9), 1408; https://doi.org/10.3390/cancers17091408

“Prunin: An Emerging Anticancer Flavonoid”
by Juie Nahushkumar Rana and Sohail Mumtaz
Int. J. Mol. Sci. 2025, 26(6), 2678; https://doi.org/10.3390/ijms26062678

“Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges”
by Ashutosh Pareek, Deepanjali Kumar, Aaushi Pareek and Madan Mohan Gupta
Cancers 2025, 17(5), 878; https://doi.org/10.3390/cancers17050878

“From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors”
by Alireza Shoari
Targets 2025, 3(1), 8; https://doi.org/10.3390/targets3010008

“Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells”
by Tânia Moura, Paula Laranjeira, Olga Caramelo, Ana M. Gil and Artur Paiva
Curr. Oncol. 2025, 32(3), 143; https://doi.org/10.3390/curroncol32030143

“Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer”
by Jennifer Haynes and Prasath Manogaran
Int. J. Mol. Sci. 2025, 26(5), 1988; https://doi.org/10.3390/ijms26051988

“Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms”
by Neha Singaravelan and Trygve O. Tollefsbol
Nutrients 2025, 17(4), 616; https://doi.org/10.3390/nu17040616

“Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment”
by Fatih Ciftci, Ali Can Özarslan, İmran Cagri Kantarci, Aslihan Yelkenci, Ozlem Tavukcuoglu and Mansour Ghorbanpour
Pharmaceutics 2025, 17(1), 121; https://doi.org/10.3390/pharmaceutics17010121

“Genetic and Epigenetic Analyses in Cancer” Guest Editor: Prof. Dr. Jing Gong Deadline for manuscript submissions: 20 April 2026	“Improving the Quality of Life in Patients with Gynecological Cancer” Guest Editor: Dr. Vasilios Pergialiotis Deadline for manuscript submissions: 20 May 2026
“Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment” Topic Editors: Dr. Won Sup Lee, Prof. Dr. Yaewon Yang and Prof. Dr. Seil Go Deadline for manuscript submissions: 31 July 2026	“Advances in Implementation Science and Knowledge Mobilization for Cancer Control” Guest Editor: Dr. Sarah Neil-Sztramko Deadline for manuscript submissions: 31 August 2026

We are delighted to share a collection of highly viewed papers in pediatric oncology that were published in Cancers (ISSN: 2072-6694) in 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Posterior Reversible Encephalopathy Syndrome in Children with Malignancies or After Hematopoietic Cell Transplantation: A Polish Nationwide Study”
by Tomasz Brzeski, Wanda Badowska, Katarzyna Mycko, Patrycja Tyszka, Martyna Korzeniewicz, Julia Kolodrubiec, Wojciech Mlynarski, Karolina Gawle-Krawczyk, Katarzyna Koch, Pawel Laguna et al.
Cancers 2025, 17(23), 3789; https://doi.org/10.3390/cancers17233789
Available online: https://www.mdpi.com/2072-6694/17/23/3789

“MicroRNA Profiling Identifies Diagnostic and Prognostic Markers in Pediatric Sarcoma”
by Terrie G. Flatt, Leonid M. Yermakov, Shreeram Akilesh, Eleanor Y. Chen, Elizabeth Gonzalez, Alejandro Parrales, Marta Zapata-Tarres, Rocio Cardenas-Cardos, Liliana Velasco-Hidalgo, Celso Corcuera-Delgado et al.
Cancers 2025, 17(23), 3791; https://doi.org/10.3390/cancers17233791
Available online: https://www.mdpi.com/2072-6694/17/23/3791

“Early BCR::ABL1 Reduction as a Predictor of Deep Molecular Response in Pediatric Chronic-Phase Chronic Myeloid Leukemia”
by Xingchen Wang, Wenbin An, Chenmeng Liu, Bang Zhang, Yunlong Chen, Yang Wan, Xiaolan Li, Lipeng Liu, Fang Liu, Li Zhang et al.
Cancers 2025, 17(24), 3994; https://doi.org/10.3390/cancers17243994
Available online: https://www.mdpi.com/2072-6694/17/24/3994

“In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma”
by Kaitlyn H. Smith, Erin M. Trovillion, Kimberly Q. McKinney, Poornima Gourabathini, Kenzie Wells, Divya Gandra, Chloe Sholler, Ingrid Votruba, Javier Oesterheld and Giselle L. Saulnier Sholler
Cancers 2025, 17(24), 4018; https://doi.org/10.3390/cancers17244018
Available online: https://www.mdpi.com/2072-6694/17/24/4018

“Histogenesis of Atypical Teratoid Rhabdoid Tumors: Anatomical and Embryological Perspectives”
by Tadanori Tomita
Cancers 2026, 18(1), 8; https://doi.org/10.3390/cancers18010008
Available online: https://www.mdpi.com/2072-6694/18/1/8

“Age-Related Clinicopathologic Patterns in Ewing Sarcoma (FET::ETS Family): A Comparative Analysis of Pediatric and Adult Patients”
by Rola H. Ali, Eiman M. A. Mohammed, Amir A. Ahmed, Ahmad R. Alsaber, Hind S. Al-Otaibi, Samer A. K. Abdulmoneim, Abdulaziz Hassan, Fatemah Almousawi, Nisreen Khalifa, Abdullah A. Ali et al.
Cancers 2026, 18(1), 133; https://doi.org/10.3390/cancers18010133
Available online: https://www.mdpi.com/2072-6694/18/1/133

Special Issues:

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share a collection of highly viewed papers in the “Cancer Epidemiology and Prevention” Section that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you: 

The list of relevant papers can be seen below: 

“A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer”
by Serafeim-Chrysovalantis Kotoulas, Dionysios Spyratos, Konstantinos Porpodis, Kalliopi Domvri, Afroditi Boutou, Evangelos Kaimakamis, Christina Mouratidou, Ioannis Alevroudis, Vasiliki Dourliou, Kalliopi Tsakiri et al.
Cancers 2025, 17(5), 882; https://doi.org/10.3390/cancers17050882
Available online: https://www.mdpi.com/2072-6694/17/5/882

“Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis”
by Yazan Abboud, Anand Shah, Madison Fraser, Eric M. Montminy, Chun-Wei Pan, Kaveh Hajifathalian, Paul J. Gaglio and Ahmed Al-Khazraji
Cancers 2025, 17(9), 1500; https://doi.org/10.3390/cancers17091500
Available online: https://www.mdpi.com/2072-6694/17/9/1500

“Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer”
by Alyssa Lange, SriGita Madiraju and Firas G. Petros
Cancers 2025, 17(4), 636; https://doi.org/10.3390/cancers17040636
Available online: https://www.mdpi.com/2072-6694/17/4/636 

“Analysis and Historical Evolution of Paediatric Bone Tumours: The Importance of Early Diagnosis in the Detection of Childhood Skeletal Malignancies”
by Giulia Iacobellis, Alessia Leggio, Cecilia Salzillo, Stefano Lucà, Ricardo Ortega-Ruiz and Ricardo Ortega-Ruiz
 Cancers 2025, 17(3), 451; https://doi.org/10.3390/cancers17030451
Available online: https://www.mdpi.com/2072-6694/17/3/451 

“Thyroid Cancer Incidence and Trends in United States and Canadian Pediatric, Adolescent, and Young Adults”
by May Z. Gao, Tariq M. Omer, Katherine M. Miller, Matthew C. Simpson, Aleksandr R. Bukatko, Kalipa Gedion, Eric Adjei Boakye, Karen M. Kost, James A. Dickinson, Mark A. Varvares et al.
Cancers 2025, 17(9), 1429; https://doi.org/10.3390/cancers17091429
Available online: https://www.mdpi.com/2072-6694/17/9/1429 

“Early Rectal Cancer: Advances in Diagnosis and Management Strategies”
by Huda Mohammed, Hadeel Mohamed, Nusyba Mohamed, Rajat Sharmand and Jayesh Sagar
Cancers 2025, 17(4), 588; https://doi.org/10.3390/cancers17040588
Available online: https://www.mdpi.com/2072-6694/17/4/588 

Special Issues: 

You are welcome to view all the special issues and submit relevant papers to the journal Cancers: https://www.mdpi.com/journal/cancers/special_issues. 

Cancers Editorial Office

We are delighted to share some highly viewed papers from the “Cancer Metastasis” Section that were published in the journal Cancers (ISSN: 2072-6694) in 2025. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

The list of relevant papers can be seen below:

“Deciphering the Blood–Brain Barrier Paradox in Brain Metastasis Development and Therapy”
by Jens Jeshu Peters, Chubei Teng, Kang Peng, and Xuejun Li
Cancers 2025, 17(2), 298; https://doi.org/10.3390/cancers17020298
Available online: https://www.mdpi.com/2072-6694/17/2/298

“Outcomes of Brain Metastasis from Lung Cancer”
by James M. Mobley, Kerry I. Phillips, Quan Chen, Ellen Reusch, Niharika Reddy, Julia B. Magsam, Laurie E. McLouth, Bin Huang and John L. Villano
Cancers 2025, 17(2), 256; https://doi.org/10.3390/cancers17020256
Available online: https://www.mdpi.com/2072-6694/17/2/256

“Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets”
by Agnieszka Dominiak, Beata Chełstowska and Grażyna Nowicka
Cancers 2025, 17(14), 2341; https://doi.org/10.3390/cancers17142341
Available online: https://www.mdpi.com/2072-6694/17/14/2341

“Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy”
by Hicham Wahnou, Riad El Kebbaj, Soufyane Hba, Zaynab Ouadghiri, Othman El Faqer, Aline Pinon, Bertrand Liagre, Youness Limami and Raphaël Emmanuel Duval
Cancers 2025, 17(7), 1232; https://doi.org/10.3390/cancers17071232
Available online: https://www.mdpi.com/2072-6694/17/7/1232

“Molecular Mechanisms of Lymphatic Metastasis in Breast Cancer: An Updated Review”
by Fatema Mahjabeen, Samrin F. Habbani and Sulma I. Mohammed
Cancers 2025, 17(13), 2134; https://doi.org/10.3390/cancers17132134
Available online: https://www.mdpi.com/2072-6694/17/13/2134

“Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions”
by Francesco Bruzzone, Chiara Barigazzi, Antonio Di Muzio, Isabel Tallarico, Angelo Dipasquale, Agnese Losurdo, Pasquale Persico, Pierina Navarria, Federico Pessina, Armando Santoro et al.
Cancers 2023, 17(9), 1591; https://doi.org/10.3390/cancers17091591
Available online: https://www.mdpi.com/2072-6694/17/9/1591

Special Issues:

“Cutaneous Metastases: State-of-the-Art Research and Management”
Guest Editors: Dr. Marios N. Papadakis and Dr. Dimitra Koumaki
Submission deadline: 30 June 2026

“Recent Advance in Colorectal Cancer Liver Metastases”
Guest Editors: Dr. Peter Metrakos and Dr. Jennifer Kalil
Submission deadline: 15 May 2026

“Advances in Locally Advanced and Metastatic Kidney Cancer (2nd Edition)”
Guest Editors: Dr. Nirmish Singla and Dr. Yasser Ged
Submission deadline: 30 April 2026

“Radiotherapy for the Management of Brain Metastases”
Guest Editor: Dr. Alla Gabriella Wernicke
Submission deadline: 31 May 2026

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2025. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer”
by Abdul Rehman, Shakta Mani Satyam, Mohamed El-Tanani, Sainath Prabhakar, Rashmi Kumari, Prakashchandra Shetty, Sara S. N. Mohammed, Zaina Nafees and Basma Alomar
Cancers 2025, 17(15), 2466; https://doi.org/10.3390/cancers17152466
Available online: https://www.mdpi.com/2072-6694/17/15/2466

“Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions”
by Saeed Rafii, Deborah Mukherji, Ashok Sebastian Komaranchath, Charbel Khalil, Faryal Iqbal, Siddig Ibrahim Abdelwahab, Amin Abyad, Ahmad Y. Abuhelwa, Lakshmikanth Gandikota and Humaid O. Al-Shamsi
Cancers 2025, 17(17), 2898; https://doi.org/10.3390/cancers17172898
Available online: https://www.mdpi.com/2072-6694/17/17/2898

“Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives”
by Omar Alomari, Habiba Eyvazova, Beyzanur Güney, Rana Al Juhmani, Hatice Odabasi, Lubna Al-Rawabdeh, Muhammed Edib Mokresh, Ufuk Erginoglu, Abdullah Keles and Mustafa K. Baskaya
Cancers 2025, 17(15), 2550; https://doi.org/10.3390/cancers17152550
Available online: https://www.mdpi.com/2072-6694/17/15/2550

“Advances and Challenges in the Management of Myelodysplastic Syndromes”
by Jessica M. Stempel, Tariq Kewan and Amer M. Zeidan
Cancers 2025, 17(15), 2469; https://doi.org/10.3390/cancers17152469
Available online: https://www.mdpi.com/2072-6694/17/15/2469

“Chronic Lymphocytic Leukemia: Novel Therapeutic Targets Under Investigation”
by Madhavi Nayyar, Ricardo C. B. de Menezes, Sikander Ailawadhi and Ricardo D. Parrondo
Cancers 2025, 17(14), 2298; https://doi.org/10.3390/cancers17142298
Available online: https://www.mdpi.com/2072-6694/17/14/2298

“Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort”
by Collins Wangulu, Davidson Zhao, Qianghua Zhou, Cuihong Wei, Rajat Kumar, Aaron Schimmer and Hong Chang
Cancers 2025, 17(9), 1405; https://doi.org/10.3390/cancers17091405
Available online: https://www.mdpi.com/2072-6694/17/9/1405

Special Issues:

“Advances in the Treatment of Relapsed and Refractory Multiple Myeloma: Novel Agents, Immunotherapies and Beyond: 2nd Edition”
Guest Editors: Prof. Dr. Klaus Podar and Prof. Dr. Xavier Leleu
Submission deadline: 15 March 2026

“Immunotherapy in Urothelial Carcinoma”
Guest Editor: Dr. Akinori Minato
Submission deadline: 31 March 2026

“Immune Landscape of Renal Cell Carcinoma”
Guest Editors: Dr. Scott S. Tykodi and Dr. Yuexin Xu
Submission deadline: 20 April 2026

“Immune-Related Adverse Events in Cancer Immunotherapy”
Guest Editors: Dr. Kate Young and Dr. Anna Olsson-Brown
Submission deadline: 15 May 2026

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office